NovoCure Limited (NASDAQ:NVCR) Receives Consensus Recommendation of Moderate Buy from Brokerages

NovoCure Limited (NASDAQ:NVCR – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine analysts that are currently covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price target among analysts […]

Related Keywords

China ,United States ,Japan ,Germany ,Optune Lua ,Optune Gio ,Frankx Leonard ,China Universal Asset Management Co ,Novocure Limited ,Wells Fargo Company ,Unisuper Management Pty Ltd ,Us Bancorp ,Jpmorgan Chase Co ,Get Free Report ,Super Management Pty Ltd ,Universal Asset Management ,Get Free ,Cure Limited ,Greater China ,Novocure Daily ,Novocure ,Nasdaq Nvcr ,Nvcr ,Medical ,Ratings ,Consensus ,